Comparative study of three vaginal markers of the premature rupture of membranes: Insulin like growth factor binding protein 1 Diamine-oxidase pH

Acta Obstetricia et Gynecologica Scandinavica

Volumn 76, Issue 6, 1997, Pages 536-540

  Gaucherand, Pascal ^a   Salle, Bruno ^a   Sergeant, Philippe ^a   Guibaud, Suzanne ^a   Brun, Jocelyne ^b   Bizollon, Charles Albert ^b   Rudigoz, R C ^a  

^a CROIX ROUSSE HOSPITAL   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Diamine oxidase (DAO); Insulin like growth factor binding protein 1 (IGFBP1); pH; Premature rupture of the membranes (PROM)

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); MARKER; SOMATOMEDIN BINDING PROTEIN 1;

ARTICLE; CLINICAL TRIAL; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PH; PREMATURE FETUS MEMBRANE RUPTURE; PRIORITY JOURNAL; RADIOENZYMATIC ASSAY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; VAGINA;

EID: 0030955823     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.3109/00016349709024579     Document Type: Article

References (20)

1. Didle AW, Hofmeister FJ. Premature rupture of the membranes. Am J Obstet Gynecol 1962; 84: 406-10.
2. Gaucherand P, Guibaud S, Rudigoz RC, Wong A. Diagnosis of premature rupture of the membrane by the identification of alpha-feto-protein in vaginal secretion. Acta Obstet Gynecol Scand 1994; 73: 456-9.
3. Gaucherand P, Guibaud S, Awada A, Rudigoz RC. Comparative study of three amniotic fluid markers in premature rupture of membranes : Fetal fibronectin, alpha-fetoprotein, diamino-oxydase. Acta Obstet Gynecol Scand 1995; 74: 118-21.
4. Abe T. The detection of the rupture of fetal membrane with the nitrozine indicator. Am J Obstet Gynecol 1940; 39: 400-4.
5. Mills AM, Garpioch DB. Use of the nitrozine yellow swab test in the diagnosis of ruptured membranes. Br J Obstet Gynaecol 1977; 84: 138-40.
6. Koninckx PR, Trappeniers H, Van Assche FA. Prolactine concentration in vaginal fluid: a new method for diagnosing ruptured membranes. Br J Obstet Gynaecol 1991; 88: 607-10.
7. Elmfors B, Tryding N, Tuffuesson G. The diagnosis of ruptured fetal membranes by measurement of the diamino-oxydase (DAO) activity in vaginal fluid. J Obstet Gynecol Br Cwlth 1974; 81: 361-2.
8. Nuber JF, Bishop P, Extermann P et al. Are vaginal fluid concentration of prolactin, alpha-foetoprotein, and human placental lactogen useful for diagnosing ruptured membranes? Br J Obstet Gynaecol 1983; 90: 1183-5.
9. Broe D, Van Dongen J, Cowley D, Vacca A. Detection of premature rupture of membranes by measuring Diamine-oxydase in vaginal fluid : False negative results by obstetric antiseptic creanes. Clin Chem 1992; 38: 784.
10. Rutanen EM. Pekonen F, Karkrainen T. Measurement of insulin like growth factor binding protein 1 in cervical vaginal secretions : comparison with the ROM-check membrane immuno-assay in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1993; 214: 73-81.
11. Lockwood CJ, Wein R, Chien D et al. Fetal membrane rupture is associated with the presence of insulin-like growth factor-binding protein 1 in vaginal secretions. Am J Obstet Gynecol 1994; 171: 146-50.
12. Ragosch V, Hundert Mark S, Fuhr N, Hopp H, Weitzel H. Management des frühen vorzeitigen Blasensprungs an geburt-shilflichen Abteilungen in Deutschland. Z Geburtsh Neonatol 1995; 199: 236-42.
13. Woltmann W, Hofstaetter C, Duderhausen JW. Nachweis eines Blasensprungs durch die Bestimmung des Insulin-like growth-factor -Bindingsprotein 1. Z Geburtsh Neonatol 1995; 199: 243-5.
14. Rutanen EM, Karkkainen TH, LehjovIrta J et al. Evaluation of a rapid strip test for insulin-like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Clin Chim Acta 1996; 253: 91-101.
15. Pannier EM, Irwin JC, Giudice LC. Insulin-like growth factor-binding proteins in human fetus: Tissue-specific protein secretion, immunologie characterization, and gene expression. Am J Obstet Gynecol 1994; 171: 746-52.
16. Koistinen R, Angervo M, Leinonen P et al. Phosphorylation of insulin-like growth factor-binding protein 1 increases in human amniotic fluid and decidua from early to late pregnancy. Clin Chim Acta 1993; 215: 189-199.
17. Hills FA, Gunn LK, Hardiman P et al. IGFBP-1 in the placenta, membranes and fetal circulation: levels at term and preterm delivery. Early Hum Dev 1996; 44: 71-6.
18. Crawford RA, Hills FA, Farkas A, Chard T. Elevated levels of insulin-like growth factor binding protein 1 in fetal distress. Br J Obstet Gynaecol 1995; 102: 538-40.
19. Chard T. Insuline-like growth factors and their binding proteins in normal and abnormal fetal growth. Growth Regul 1994; 4: 91-100.
20. Wang HS, Lee CL, Chard T. Levels of insulin-like growth factor 1 and insulin-like growth factor-binding protein-1 in pregnancy with preterm delivery. Br J Obstet Gynaecol 1993; 100: 472-5.